The mutation and overexpression of the epidermal growth factor receptor (EGFR) are associated with the development of a variety of cancers, making this prototypical dimerization-activated receptor tyrosine kinase a prominent target of cancer drugs. Using long-timescale molecular dynamics simulations, we find that the N lobe dimerization interface of the wild-type EGFR kinase domain is intrinsically disordered and that it becomes ordered only upon dimerization. Our simulations suggest, moreover, that some cancer-linked mutations distal to the dimerization interface, particularly the widespread L834R mutation (also referred to as L858R), facilitate EGFR dimerization by suppressing this local disorder. Corroborating these findings, our biophysical experiments and kinase enzymatic assays indicate that the L834R mutation causes abnormally high activity primarily by promoting EGFR dimerization rather than by allowing activation without dimerization. We also find that phosphorylation of EGFR kinase domain at Tyr845 may suppress the intrinsic disorder, suggesting a molecular mechanism for autonomous EGFR signaling.
INTRODUCTION
Epidermal growth factor receptor (EGFR), one of the most studied receptor tyrosine kinases, represents both a prototypical cell-surface receptor and a prime cancer drug target. The EGFR family (that also includes three other members, Her2-4), plays a critical role in the regulation of cell proliferation, differentiation, and migration (Yarden and Sliwkowski, 2001) .
The mutation and overexpression of EGFR receptor tyrosine kinases have been implicated in the growth of a host of human cancers, and a number of EGFR and Her2 inhibitors are currently available to patients of lung, pancreatic, and other cancers. In nonsmoker and East Asian lung cancer patients, mutations at the EGFR kinase domain are particularly common (Sharma and Settleman, 2009; Mitsudomi and Yatabe, 2010) , and their presence is positively correlated with the success of treatment by EGFR-kinase inhibitors, including gefitinib and erlotinib (Lynch et al., 2004; Paez et al., 2004; Pao et al., 2004) . L834R, which accounts for $40% of such mutations, is the most commonly observed single-residue mutation in this group (Figure 1A) . (This mutation is also referred to as L858R, corresponding to an EGFR residue-numbering scheme that includes the 24-residue membrane-targeting signal sequence; the convention used in this study excludes those residues, which are deleted in the mature protein. ) In light of the clinical importance of the L834R mutation in lung cancer, understanding the unique properties of the mutant kinase is crucial to lung cancer biology and to drug development. More generally, understanding how cancer mutants of a protein differ from each other and from the wild-type at a molecular level may potentially lead to personalized cancer treatment tailored according to the genetic makeup of a cancer patient.
It has been well established that the activation of wild-type EGFR is primarily driven by ligand-binding-induced receptor dimerization (Schlessinger, 2000) . In vitro assays have shown that L834R and other cancer mutants of EGFR kinase are enzymatically more active than the wild-type under comparable conditions (Zhang et al., 2006; Yun et al., 2007) . These mutations are generally assumed to give rise to spontaneous kinase activation, eliminating the dependence of the cancer mutants on dimerization for activation. It is thus puzzling that, in vivo, dimerization remains necessary for robust activity of the L834R mutant (Zhang et al., 2007) . In the present study, we use long-timescale molecular dynamics (MD) simulations to compare the EGFR wild-type and L834R, among other cancer mutants, in order to probe the molecular mechanism that gives rise to aberrant signaling.
EGFR activation depends on the formation of asymmetric dimers (Zhang et al., 2006) , in which one EGFR kinase (the ''activator'') stabilizes the other (the ''receiver'') ( Figure 1D ) in the ''aC-in active'' conformation, which is characterized by placement of the aC helix such that the catalytically important KE salt bridge between Lys721 and Glu738 is maintained. EGFR kinase also adopts the ''aC-out inactive'' conformation (Wood et al., 2004; Jura et al., 2009) , in which the aC helix is displaced and the KE salt bridge is broken. This conformation is frequently referred to as the ''Src/CDK2-like inactive'' conformation for its resemblance to the inactive conformations of Src and CDK2 kinases ( Figure 1C) .
In this study, we observe the presence of a functionally important third conformation, in which EGFR kinase exhibits local intrinsic disorder (partial unfolding) at the region of the receiver interface, particularly at the aC helix ( Figure 1B ). Intrinsic disorder is widely known to play an important role in the function of signaling proteins (Dunker et al., 2002) . Although EGFR signaling involves multiple layers of controlling mechanisms, our identification of an intrinsically disordered state of EGFR kinase introduces another element that may be critical for its function. Our simulations suggest that the oncogenic L834R mutation may cause aberrant activity by suppressing the local intrinsic disorder, increasing the dimerization affinity of EGFR and thus lowering the threshold for EGFR activation. Confirming our computational predictions, we show that the L834R mutant exhibits a much higher dimerization affinity than wild-type and provide evidence that the higher overall activity of the L834R mutant is due primarily to its propensity to dimerize. We also show that the intrinsic disorder of EGFR may be similarly suppressed by the phosphorylation of Tyr845 in the activation loop, suggesting that Tyr845 phosphorylation may regulate the autonomous lateral propagation of EGFR signals, a mechanism by which signals are transmitted from one EGFR molecule to another without requiring the binding of growth factors (Verveer et al., 2000) .
RESULTS

Lapatinib Binding Kinetics Suggests a Third Conformation of EGFR Kinase
We found an initial indication of the existence of a third EGFR kinase conformation by performing a computational study of drug binding kinetics. In particular, we simulated the binding to EGFR kinase of lapatinib (Movie S1 available online), a drug known for its unusually slow binding kinetics (Wood et al., 2004) . Lapatinib, which is used to treat breast cancer and other solid tumors, is known to bind to EGFR and Her2 kinases in the Src/CDK2-like inactive conformations.
We initiated simulations with lapatinib molecules positioned at random around an unliganded EGFR kinase in the Src/CDK2-like inactive conformation. In four separate simulations with a total duration of 47 ms, lapatinib bound to EGFR twice, in each case adopting a bound pose virtually identical to that observed crystallographically (Figure 2 ). These two binding events each occurred after $7 ms of simulation; the remaining two simulations, in which no binding event occurred, totaled 25 ms. These simulations imply an on-rate of $3.1 s À1 mM À1 (or >0.83 s À1 mM
À1
with 90% confidence) for lapatinib biding to EGFR, which is significantly higher than the experimentally derived on-rate of $0.02 s À1 mM À1 (3.0 nM dissociation constant and 300 min half-life for the EGFR-lapatinib complex [Wood et al., 2004] ). We believe this large discrepancy is unlikely to be entirely attributable to simulation artifacts, because a number of other ligand binding simulations have produced reasonably accurate binding kinetics Dror et al., 2011) . In this study, (B) An EGFR kinase monomer in the conformation that exhibits intrinsic disorder at the aC-helix region. The aC helix is largely dissolved and the catalytically important Lys721-Glu738 salt bridge is broken, whereas the b9 strand is intact. (C) An EGFR kinase in the Src/CDK2-like inactive conformation, where the aC helix is packed against a short helix that takes the place of the b9 strand. (D) An activated EGFR kinase in an asymmetric dimer. The active conformation is distinguished by the intact Lys721-Glu738 salt bridge. Next to the cartoons in (B-D) are ribbon renderings of the corresponding conformations of the aC helix region, with Lys721, Glu738, and the distance between these two residues shown.
we also performed similar simulations involving gefitinib, another cancer drug that differs from lapatinib in that it binds to the active aC-in conformation of EGFR. These simulations, with the kinase in its aC-in conformation, not only captured the correct gefitinib binding pose ( Figure S1 ), but led to an estimated binding on-rate (5.9 s À1 mM À1 , or >2.2 s À1 mM À1 with 90% confidence) close to gefitinib's experimentally derived on-rate of 6.23 s À1 mM
(0.19 ± 0.11 nM dissociation constant and 9 min half-life for the EGFR-gefitnib complex [Gilmer et al., 2008] ). Our simulations suggest that the slow kinetics of lapatinib-EGFR binding are due not to intrinsic properties of the Src/ CDK2-like inactive conformation, but instead to a rate-limiting transition of EGFR kinase from some other, predominant conformation to the Src/CDK2-like inactive conformation. If this is the case, this predominant conformation could not be the aC-in active kinase conformation because EGFR kinases are enzymatically weak in monomeric form. We thus suspect the presence of a third EGFR kinase conformation, and in the following discussion we will attempt to elucidate the structural properties and functional significance of this third conformational state of EGFR kinase.
Simulations Suggest Local Intrinsic Disorder of EGFR Kinase, but Not of Src Kinase The activation of EGFR kinase depends on the formation of active dimers, in which the C lobe of the activator kinase interacts with the N lobe of the receiver, stabilizing the catalytically active conformation of the latter ( Figure 1D ). We began by simulating monomeric EGFR kinase from its active conformation, with the expectation that, in the absence of the activator kinase, a conformational change from the aC-in conformation would occur over a timescale of microseconds to milliseconds, as is typical of large-scale protein conformational changes (Kay, 1998) . Surprisingly, the EGFR kinase repeatedly escaped the aC-in conformation on a much shorter timescale of $100 ns (Figure 3A) , transitioning to an aC-out conformation ( Figure 3B ) that differs from the Src/CDK2-like (aC-out) inactive conformation.
How is such an unusually fast conformational change realized? The presence of fast conformational-change kinetics is often associated with intrinsic disorder (e.g., Baker et al., 2007) . Our simulations consistently show that in leaving the initial aC-in conformation, the EGFR kinase arrives at a state in which the aC-helix region of the receiver interface is conformationally disordered. In this state, the KE salt bridge is broken and the aC helix itself is partially unfolded ( Figure 3B ). In contrast, the activator interface at the C lobe of EGFR kinase remains stable ( Figure S2H ).
To the best of our knowledge, the intrinsic disorder of EGFR kinase has not been discussed previously, but our survey of crystal structures finds supporting evidence for intrinsic disorder in EGFR kinase. In particular, the crystal structure (Protein Data Bank [PDB] entry 2RF9) of EGFR kinase ( Figure 3B ; Zhang et al., 2007) is highly consistent with the disordered state we identified; the unresolved region in the crystal structure coincides with the disordered region in our simulations, and the conformation of the resolved region is consistent with that observed in our simulations in terms of the position of the ordered portion of the aC helix and the intact b9 strand.
Traces of the intrinsic disorder in EGFR are also reflected in B factors: the vicinity of the putatively disordered region (the N-terminal part of the aC helix, the b3-aC loop, the P loop, and the activation loop) exhibits the highest B factors in EGFR crystal structures ( Figure 3C ).
In addition, we carried out simulations of Src kinase, a prototypical tyrosine kinase. In contrast to EGFR, the aC-in conformation of Src remained stable in 10-ms simulations. The KE salt bridge was maintained throughout the simulation (Figure 3A) . We also performed an independent bioinformatics analysis and found it to predict the presence of intrinsic disorder at the aC-helix in EGFR (particularly the part N-terminal to Glu738), but not in that of Src ( Figure 3D ).
The crystallographic evidence discussed above supports the idea that EGFR may feature a partially disordered state and that our simulations are sufficiently accurate to distinguish between kinases with and without the disorder. Hydrogen/deuterium (H/D) exchange experiments lend further support to this conclusion.
H/D Exchange Measurements Confirm Local Disorder of EGFR Kinase
To verify the presence of intrinsic disorder in EGFR kinase, H/D exchange experiments were performed to characterize the 
. Simulations of Lapatinib Binding to EGFR Kinase
(A) The root-mean-square deviation (rmsd) of lapatinib's position in the binding simulations with respect to its crystallographically determined native pose. The rmsd is calculated based on the alignment of the protein conformation with respect to the crystal structure. The inset shows snapshots of lapatinib during a simulation color-coded by the simulation time. Note that lapatinib enters its binding pocket between the hinge region and the P loop, the only persistent gateway to the binding site (see Movie S1). (B) The simulation-generated lapatinib binding pose compared with that of the crystal structure (PDB entry 1XKK). The methylsulfonyl group extends beyond the ATP-binding site of EGFR kinase, and our simulations find it to be the most flexible part of lapatinib in the bound state. The protein is cropped to show lapatinib clearly. For related simulations of gefitinib binding to EGFR, see also Figure S1 . dynamic properties of both EGFR and Src kinases. The resulting data lends further support to the notion of a unique, intrinsic disorder at the aC helix region of the EGFR kinase. Consistent with the notion that EGFR kinases primarily function in dimer forms, H/D measurements demonstrate that monomeric EGFR kinase, which has higher H/D exchange rates overall, is significantly more dynamic than Src ( Figure S2F) . Indeed, the H/D exchange rates of EGFR are significantly higher at the vicinity of the receiver interface (the C-terminal portion of the aC helix, the aC-b4 loop, and the b4 and b5 strands; Figure 3F ). Distinctive differences are also seen at the aE helix, the catalytic loop, and the residues between the HRD and the DFG motifs. These residues are adjacent either to the C-terminal of the aC helix (the C-terminal part of the aE helix and part of the catalytic loop), or to the hinge region that controls the relative motions of the N and the C lobes and the conformation of the ATP-binding site.
The Inferred Free-Energy Landscape of EGFR Kinase
Src and CDK2 kinases feature a two-basin free-energy landscape (Banavali and Roux, 2009; Berteotti et al., 2009) in which a significant free-energy barrier separates the two basins, which correspond to the active and the inactive conformations. Transitions between these conformations require that this barrier be crossed, a process that takes place on a timescale of microseconds to milliseconds. The energy landscape may be altered to favor the active conformation by protein-protein interactions or by phosphorylation.
Our simulations, however, suggest a distinctive three-state energy landscape for monomer EGFR kinase ( Figure 3E ). As discussed previously, the active conformation is highly unstable in wild-type EGFR, suggesting that this conformation has a high free energy. In addition, the fact that transitions from the active to the disordered state occur on a nanosecond timescale implies a downhill transition with minimal energetic barriers-that is, the typical energetic basin for the active conformation is absent. On the other hand, there is a well-formed basin corresponding to the Src/CDK2-like inactive conformation; as a result, EGFR kinase remains stable in this conformation for as long as 100 ms in simulation ( Figure S2E ). Because the disordered and Src/CDK2-like inactive conformations do not interconvert on the simulation timescale, we are unable to determine which is more stable. The slow lapatinib binding kinetics, which imply that binding involves a rate-limiting conformational change toward the Src/ CDK2-like inactive conformation, suggest that the disordered conformation, rather than the Src/CDK2-like inactive conformation, is likely predominant in monomeric EGFR kinases.
An important feature of this putative three-state energy landscape is the relatively high free energy associated with the active conformation, which should hinder EGFR dimerization, given that EGFR kinases need to adopt the active conformation in the formation of asymmetric dimers. The high free energy of the active conformation of EGFR kinase may be explained by the relatively large patch of solvent-exposed hydrophobic surface ($590 Å 2 ) at the receiver dimer interface ( Figure S2D ), which is much larger than the corresponding hydrophobic patch ($360 Å 2 ) in Src. This is confirmed by MD simulations of EGFR kinase solvated by a mixture of water and isopropyl alcohol (iPrOH), a simulation procedure originally designed for the identification of potential drug-binding sites on protein surfaces (Seco et al., 2009) . Notably, the active conformation is stabilized in this simulation, and the local intrinsic disorder is suppressed by the aggregation of isopropyl alcohol (iPrOH) molecules at the receiver and activator interfaces (Figures S2A-S2D ). This observation also suggests that the dimerization of EGFR kinase is driven largely by a hydrophobic effect, as is typical of proteinprotein interactions (Lo Conte et al., 1999) .
The Intrinsic Disorder of the Receiver Kinase Is Suppressed in the Activated Dimer Wild-type EGFR kinases by themselves exist predominantly as monomers (Figure 4) , indicative of a free-energy cost associated with their dimerization. The overlap of the disordered region and the receiver interface suggests a folding-upon-binding process (Levy et al., 2005; Mittag et al., 2010; Wright and Dyson, 2009) for the dimerization of EGFR kinases, in which the receiver kinase adopts a specific, ordered conformation upon binding. Indeed, simulations of the asymmetric dimer suggest that dimerization suppresses the intrinsic disorder at the receiver interface, stabilizing the active conformation of the receiver kinase ( Figure 5A ). As a result, the KE salt bridge is stable in the receiver kinase, but not in the activator. Conversely, we anticipate that allosteric stabilization of the dimer interface through suppression of the intrinsic disorder would promote dimerization.
L834R Allosterically Suppresses the Disordered State and Promotes Dimerization
From crystal structures of a number of EGFR kinase mutants, which broadly resemble those of the wild-type (Yun et al., 2007 (Yun et al., , 2008 , it is not immediately clear how the L834R mutation alters the function of EGFR. Several molecular dynamics studies have been carried out at a nanosecond timescale to investigate the characteristics of L834R and other cancer mutants (Liu et al., 2006; Papakyriakou et al., 2009; Dixit and Verkhivker, 2009) , the results of which suggested that the cancer mutations may favor the active aC-in conformations and disfavor the Src/CDK2-like inactive conformation, but have not raised the possibility of an additional, disordered conformation.
In microsecond-timescale simulations, we found that transitions from the aC-in active conformation to the disordered conformation take place far more slowly in the L834R mutant than in the wild-type, suggesting that the L834R mutation stabilizes the aC-in active conformation relative to the disordered state. In the L834R mutant, the positively charged Arg834 was surrounded by a cluster of negatively charged residues (Glu734, Asp831, and Asp813). As a result of these favorable interactions, the aC helix exhibited higher stability and the KE salt bridge remained intact for 2-30 ms, as opposed to tens of nanoseconds for the wild-type ( Figures 5C and S4 ). Although these observations are kinetic in nature, they likely reflect an underlying change of the free-energy landscape due to the L834R mutation ( Figure 3E) . Overall, such a change favors the active conformation at the expense of the disordered state and as a result promotes EGFR dimerization.
Confirming our prediction of higher dimerization affinity of the L834R mutant than the wild-type, light scattering and native gel show that wild-type EGFR kinases generally exist as monomers The locally disordered conformation captured by X-ray crystallography. The orange represents a crystal structure (PDB entry 2ITP) of the active conformation (the starting point of the simulations). The blue ribbon represents the crystal structure (PDB entry 2RF9) that resembles the simulation-generated disordered conformation (red), in which part of the aC helix is disordered and the Lys721-Glu738 salt bridge is disrupted while the b9 strand is intact. The blue dashed line represents the unresolved region in the crystal structure.
(C) B factors of EGFR crystal structures. The N-terminal portion of the aC helix, the b3-aC loop, the P and the activation loop are consistently the regions of high flexibility as suggested by the high B factors (red).
(D) Bioinformatics analysis (Schlessinger and Rost, 2005) predicts intrinsic disorder at the aC helix for EGFR kinase but not for Src and CDK2.
(E) Cartoons of the inferred free-energy landscapes of wild-type EGFR kinase and mutants. Note that the free energy of the active conformation is lowered by EGFR cancer mutations.
(F) Region-specific hydrogen/deuterium (H/D) exchange rates of EGFR and Src kinase in the vicinity of the aC helix. The residues in EGFR kinase that are involved in the receiver interfaces of the asymmetric dimer and their corresponding residues in Src are highlighted. The exchange rates of the disordered region of EGFR whereas L834R proteins preferentially form dimers and oligomers in solution ( Figures 4A and 4B) . From light scattering, the inferred molecular weights of L834R are consistent with those of monomers or dimers. In contrast, the inferred molecular weights of the wild-type correspond only to monomers. Consistent with these findings, in our native gel analysis the L834R mutant exhibited a striking ladder-like pattern, indicating the presence of the asymmetric dimers and even higher-order kinase are significantly higher than those of the corresponding region in Src. The H/D exchange measurements were carried out at pH 6.0 and pH 7.0. Each row of the data represents an incubation time; from top to bottom, the incubation times at pH 6.0 are 30, 100, 300, 1,000, and 3,000 s, and those at pH 7.0 are 30, 100, 300, and 1,000 s. For additional H/D exchange data, the stability of the Src-like conformation or the activator interface, and the stabilizing effect of isopropyl alcohol on EGFR kinase, see also Figure S2 . (Monsey et al., 2010) , the activity of Her2 kinase is relatively weak. The activity of L834R at 18 mM was underestimated presumably due to substrate/ATP depletion in the measurement and is ignored in the curve fitting. For the denaturing gel of the protein samples used in the enzymatic assays, see also Figure S3 .
oligomers, whereas the wild-type ran as a single band, presumably as monomers ( Figure 4B ). The L834R oligomers are possible because the asymmetric dimers are open-ended structurally.
Additionally, H/D exchange experiments were carried out on the L834R mutant as well as the wild-type. The resulting H/D exchange profiles ( Figure S2G ) do not obviously distinguish the wild-type from the mutant, suggesting that the disordered state remains predominant in the mutant. This finding is consistent with our simulation of L834R, in which the disordered state was eventually reached, albeit after a substantially longer time than for the wild-type ( Figure 5C ). Given the limited sensitivity of H/D exchange experiments to changes in the fraction of a slowly exchanging minority state, the H/D exchange results appear consistent with the inference drawn from simulations that the mutation lowers the free energy of the minority (active) state toward that of the predominant disordered state ( Figure 3E ).
Further simulations of L834R in the Src/CDK2-like inactive conformation show that Arg834 engages in favorable interactions ( Figure S2E ) and stabilizes this conformation, rather than destabilizing it as some previous studies have suggested. It is thus unlikely that the cancer mutation stabilizes the active conformation at the expense of the Src/CDK2-like inactive conformation. Instead, stabilization of the active conformation is likely achieved at the expense of the disordered conformation.
The impact of the L834R mutation on the activator interface, compared to the receiver interface, appears limited. It was shown (Zhang et al., 2007) that, like the wild-type, the activity of the kinase-dead and activator-only L834R mutant (D813N/ I682N/L834R) cotransfected with the receiver-only mutant (V924R) remains dependent on EGF stimulus, indicating that the L834R mutation does not affect the activator interface significantly. In contrast, when the L834R mutation is introduced to the receiver-only mutant, as in cotransfection of I682N/D813N/ L834R and V924R/L834R, the activity becomes much higher in absence of EGF, reflecting the impact of the L834R mutation on the receiver interface. Consistent with these findings, simulations showed that the conformational dynamics of the region of the activator interface of the L834R mutant does not differ from the wild-type in any obvious way ( Figure S2I ).
Elevated Dimerization Affinity Underlies the Aberrant Activity of L834R
Consistent with an elevated dimerization affinity, enzymatic assays show that L834R reaches its peak kinase activity at a much lower concentration than does the wild-type ( Figures 4C  and S3A) . As a result, the threshold for activation is lower and the cancer mutant is catalytically more active than the wildtype, especially at relatively low concentrations. The assays further show that the aberrant activity of the L834R cancer mutant in the absence of an EGF signal may arise primarily from the higher dimerization affinity than from the modest (2-fold) increase in intrinsic catalytic potency (estimated to be 0.21 s À1 for L834R as opposed to 0.09 s À1 for the wild-type).
At 25 nM concentration, for example, L834R is as much as 60 times more active than the wild-type (specific activity of 0.042 s À1 compared to 0.00066 s À1 ); this difference is thus predominantly attributable to the change of dimerization affinity forms a stable interaction with Lys836, resulting in the stabilization of the active conformation and the aC helix. Note that the Lys836-pTyr845 interaction is conserved in many phosphorylated protein tyrosine kinases.
(C and D) In the left panels, the main interactions of the mutated residues in cancer mutants L834R and S744I are shown. KE salt bridge remained intact much longer during simulations of these mutants than in simulations of the wild-type. For the enhanced helicity at the aC-helix region due to cancer mutations and Tyr845 phosphorylation, see also Figure S4 .
by the cancer mutation. The increased activity of L834R, due to higher dimerization affinity, rather than to an increase in intrinsic catalytic potency, explains the need for EGFR dimerization for robust autophosphorylation of the L834R mutant in vivo, as it is for the wild-type (Zhang et al., 2007) .
Simulations of Other Cancer EGFR Mutants
Besides L834R, we have studied a number of additional EGFR cancer mutants that have been identified in NSCLC patients, including S744I, G695S, L837Q, and Del722-726, which entails a five-residue deletion of residues 722-726. Although the mutation sites vary, our simulations suggest that in these mutants, as in L834R, the active aC in conformation is stabilized compared to the wild-type (Figures 5 and S4) . Presumably, both Del722-726 and G695S rigidify the b3-aC loop and reduce the local disorder at the aC-helix region-the former by shortening the b3-aC loop and the latter by reducing the flexibility of the P loop, which is dynamically coupled with the b3-aC loop. L837Q and S744I mutations most likely enthalpically stabilize the active aC-in conformation by engaging with the residues of the aC helix and residues of the adjacent b9 strand respectively. L837Q allows new hydrogen bonds near the C-terminal of the aC helix, whereas S744I improves hydrophobic packing between the aC helix and the b9 strand.
Active Conformations of Her2 and Her4 Kinases Display Increased Stability
What is the functional role of the disorder? Extension of this study from EGFR to other members of EGFR family may help answer this question. We thus examined whether the disorder may be observed in Her2 and Her4 kinases, which both share 81% sequence identity with EGFR and a similar activation mechanism (Monsey et al., 2010) . (Her3 is a pseudokinase that dimerizes with the other receptors of the EGFR family [Paez et al., 2004] as an activator.) We also considered cyclin-dependent kinase 2 (CDK2), because the way in which the activator kinase activates the receiver in EGFR resembles the way in which cyclin A activates CDK2 (Zhang et al., 2006) ; CDK2 and the receiver EGFR kinase appear to exploit similar proteinprotein interfaces at similar locations. Because of the close homology, one might expect Her2 dynamics to be highly similar to EGFR. In our simulation of Her2 kinase, however, the local intrinsic disorder was not observed; the aC-in conformation remained stable throughout a 20-ms simulation (Figure 6 ). The more stable receiver interface of Her2 allowed the kinase to dimerize more readily, consistent with the role of Her2 as a preferred heterodimeric partner.
Her2 activity assays ( Figure 4C ) show that Her2 dimerizes more readily than EGFR wild-type. Because the residues directly in contact with the other monomer in an active dimer are highly conserved between Her2 and EGFR, this difference in dimerization may only be attributed to the difference in the conformational stability required for the dimerization.
Simulations of Her4 also show a stable aC-in conformation and the absence of local intrinsic disorder (Figure 6 ). This contrast between Her2 and Her4 on the one hand and EGFR on the other suggests that EGFR kinase is unique in the family for its pronounced intrinsic disorder at the receiver interface. A stable aC-in conformation is observed in CDK2 kinase as well, despite the fact that the activation of CDK2 kinase resembles EGFR activation structurally (Figure 3 ).
DISCUSSION
EGFR dimerization, which leads to catalytic activation and subsequent EGFR signaling, is driven primarily by the binding of growth factors to the extracellular segment of the receptor. Some EGFR components, such as the transmembrane and the juxtamembrane segments, are known to promote dimerization (Mendrola et al., 2002; Jura et al., 2009 ). On the other hand, the extracellular segments are disinclined to dimerize without the binding of growth factors (Odaka et al., 1997) , and our experiments have shown that the dimerization affinity of the cytoplasmic kinase domains is weak. These components contribute to a bias against EGFR dimerization in the absence of EGF. Even with EGF bound, the extracellular segments of EGFR dimerize with a moderate affinity of K d z 2.4 mM (Odaka et al., 1997; Burgess et al., 2003; Ogiso et al., 2002 dimerization is sufficiently weak that it may be overcome by the moderate affinity increase due to EGF binding. In this context, we suggest that the intrinsic disorder of the kinase domain may be critical to the overall balance that dictates EGFR dimerization and ultimately regulates EGFR signaling. Cancer mutations that allosterically suppress the intrinsic disorder shift the balance toward EGFR dimerization and consequently alter EGFR basal activity and the intensity and duration of EGFR signaling in response to an EGF stimulus. We note that the higher kinase activity of the EGFR L834R cancer mutant (relative to the wild-type) owes more to a decreased threshold for dimerization-mediated activation than to the enhanced intrinsic catalytic potency of the mutant. In other words, the mutant is predisposed to dimerize.
Protein kinase domains are known to exhibit complex conformational dynamics in regulation and in catalytic cycles (Masterson et al., 2010; Shan et al., 2009) . Although EGFR kinase has not previously been reported to display intrinsic disorder, intrinsically disordered proteins are prevalent, accounting for 15% of all eukaryotic proteins (Ward et al., 2004) . Because of its role in complex molecular functions, intrinsic disorder is believed to be even more prevalent among regulatory and signaling proteins (Ward et al., 2004) . It has been suggested that, among many other functional roles (Tompa, 2010) , intrinsic disorder allows proteins to engage in weak, yet specific interactions with multiple partners (Cortese et al., 2008) , and it facilitates faster kinetics of molecular recognition (Zhou, 2012) . Intriguingly, the intrinsic disorder in human EGFR kinase may be a more recently evolved characteristic associated with more complex function. Our simulation showed that the intrinsic disorder is apparently absent in the more ancient invertebrate EGFR (iEGFR) kinase in Drosophila melanogaster (Figure 6 ), which shares a 58% sequence identity to its human counterpart.
If intrinsic disorder indeed plays a critical role in EGFR activation, is this disorder regulated? In particular, might EGFR dimerization be regulated not only extracellularly by ligand binding but also cytoplasmically? Here we present a hypothesis for such a cytoplasmic mechanism based on the phosphorylation of the kinase domains at Tyr845.
Tyr845 of EGFR kinase represents a highly conserved tyrosine in the activation loop of protein tyrosine kinases. The phosphorylation of this residue is typically involved in the activation of a tyrosine kinase (Huse and Kuriyan, 2002) . Although Tyr845 phosphorylation is not required for the activation of EGFR kinase (Gotoh et al., 1992) , it remains closely involved in the regulation of EGFR function as well as in tumor progression (Khan et al., 2008) . In particular, Tyr845 phosphorylation has been observed to follow an EGF stimulus (Choi et al., 2007; Qiu et al., 2009 ). Y845F mutation is known to lead to dramatic ablation of EGFinduced DNA synthesis (Biscardi et al., 1999) and to a significant decrease in phosphorylation of the receptor (Huang et al., 2010) . It remains unclear, however, by what mechanism the phosphorylation impacts EGFR signaling.
Our simulations demonstrated that Tyr845 phosphorylation at the activation loop suppresses the intrinsic disorder and secures the aC-in conformation ( Figure 5 ). This effect appears to be realized through the buttressing of the b9 strand via the salt bridge between the phosphotyrosine and Lys836. As simulation work on Her2 kinase has suggested, the activation loop and the aC helix are generally coupled and phosphorylation at the activation loop tends to favor the aC-in conformation (Telesco and Radhakrishnan, 2009 ). Kinase assays on the Y845E mutant, where the mutation is introduced as a mimic of the phosphorylation, lends support to the simulation finding regarding Tyr845. The assays showed that the mutation produces a modest increase in the dimerization affinity ( Figure 4C ). Glutamate is known to be an imperfect mimic of phosphotyrosine. Tyr845 phosphorylation is likely more potent than the mutation mimic in promoting EGFR dimerization. In addition, in vivo data have shown that the L834R mutation is associated with an elevated level of Tyr845 phosphorylation (Choi et al., 2007) , and thus it is tempting to speculate that the effect of L834R is amplified by W845 phosphorylation.
In light of these findings, we propose a mechanism for lateral signal propagation centered on Tyr845 phosphorylation. Unlike the ''vertical'' signal propagation that is directly induced by EGF binding, lateral propagation refers to the autonomous signaling process arising from interaction among EGFRs themselves. Lateral signal propagation has been suggested to be an integral part of EGFR signaling (Ichinose et al., 2004; Verveer et al., 2000) and, in particular, signal amplification.
We propose that EGFR activation and Tyr845 phosphorylation are part of a self-sustained signal propagation and amplification process. In this proposed mechanism, extracellular ligand binding initially leads to activation of a subset of EGFR molecules. Other EGFRs may then be phosphorylated at Tyr845, primed for dimerization, and consequently activated cytoplasmically ( Figure 7 ). (It is not essential to this mechanism whether Tyr845 phosphorylation in vivo is carried out through EGFR autophosphorylation [Qiu et al., 2009] or through other kinases [Biscardi et al., 1999] .) In isolation this process might expand exponentially, but in vivo it may be dampened by Tyr845 dephosphorylation by protein tyrosine phosphatases (PTPs), the inhibition of which has been shown to promote lateral signal propagation (Reynolds et al., 2003) . If the role of Tyr845 A cartoon model for lateral propagation based on Tyr845 phosphorylation. The EGF-bound dimer (center) is activated first. In addition to phosphorylating the C-terminal tails of the EGFRs and setting off a downstream signal cascade, this activated dimer may promote secondary dimerization and autonomous activation (independent of EGF binding) by phosphorylating other EGFR kinases at Tyr845. Such a process may be self-sustained and may be attenuated by protein tyrosine phosphatases. phosphorylation in promoting EGFR dimerization is confirmed, an interesting question may arise as to whether this could lead to a mechanism for ''inside-out'' EGFR signaling.
EXPERIMENTAL PROCEDURES
We summarize our computational and experimental procedures below; additional detail is provided in the Supplemental Information.
Molecular Dynamics
The simulations of EGFR kinase starting from the Src/CDK2-like inactive conformation were based on PDB entry 2GS7. The simulations of lapatinib and gefitinib binding were initiated from PDB entries 1XKK and 2ITO, respectively. All other EGFR simulations were based on PDB entry 2ITP. The simulations of Her2, Her4, CDK2, and Src kinases were based on PDB entries 3PP0, 3BCE, 1FIN, and 1Y57, respectively. We used the Anton specialized hardware ) and the modified Amber99SB protein force field (LindorffLarsen et al., 2010) to perform the simulations.
Hydrogen/Deuterium Exchange Mass Spectrometry and Static Light Scattering Hydrogen/deuterium exchange rates were measured using mass spectrometry (Yoshitomo Hamuro, ExSAR, Monmouth Junction, NJ). Static light scattering experiments were performed as described previously (Zhang et al., 2006) .
Kinase Activity Assays
Kinase activity was measured using radiometric assays (Edward Esposito, Blue Sky Biotech, Worcester, MA). Poly(Glu4Tyr) substrate was used. The EGFR constructs in these assays included residues 672-998; the Her2 construct included residues 705-1029. All constructs included an N-terminal His tag.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four figures, and one movie and can be found with this article online at doi:10.1016/j.cell.2012.02.063.
